Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxacillin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.83 |
| ▸ | ABCB11 | O95342 | 4/20 | 0.78 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.73 |
| ▸ | HPGD | P15428 | 3/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.64 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.59 |
| ▸ | HRH1 | P35367 | 1/20 | 0.54 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxacillin SCHEMBL3107021 | 0.99 | ALDH1A1 (0.82) | ALDH1A1SMN1; SMN2ABCB11CYP1A2HPGD | |
| Oxacillin SCHEMBL8722495 | 0.99 | ALDH1A1 (0.85) | ALDH1A1SMN1; SMN2ABCB11CYP1A2HPGD | |
| Oxacillin SCHEMBL14126543 | 0.99 | ALDH1A1 (0.85) | ALDH1A1SMN1; SMN2ABCB11CYP1A2HPGD | |
| Oxacillin SCHEMBL4780815 | 0.99 | ALDH1A1 (0.85) | ALDH1A1SMN1; SMN2ABCB11CYP1A2HPGD | |
| Oxacillin SCHEMBL9876911 | 0.99 | ALDH1A1 (0.85) | ALDH1A1SMN1; SMN2ABCB11CYP1A2HPGD | |
| Oxacillin SCHEMBL15387553 | 0.99 | ALDH1A1 (0.85) | ALDH1A1SMN1; SMN2ABCB11CYP1A2HPGD | |
| Oxacillin SCHEMBL8724789 | 0.99 | ALDH1A1 (0.85) | ALDH1A1SMN1; SMN2ABCB11CYP1A2HPGD | |
| Oxacillin SCHEMBL3817 | 0.99 | ALDH1A1 (0.85) | ALDH1A1SMN1; SMN2ABCB11CYP1A2HPGD | |
| Oxacillin SCHEMBL18048119 | 0.99 | ALDH1A1 (0.85) | ALDH1A1SMN1; SMN2ABCB11CYP1A2HPGD | |
| Oxacillin SCHEMBL28938009 | 0.98 | ALDH1A1 (0.83) | ALDH1A1SMN1; SMN2ABCB11CYP1A2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3266 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250312046-A1 | LIGATION CLIP AND PREPARATION METHOD THEREOF | SICHUAN GUONA TECHNOLOGY CO., LTD. (CN) | 2025-10-09 | — | — | US | claimed |
| EP-4628110-A1 | LIGATING CLIP | Chengdu Guona Technology Co., Ltd (CN) | 2025-10-08 | — | — | EP | claimed |
| CN-120131556-A | Oxacillin sodium composition for injection and preparation method thereof | 成都晶富医药科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| WO-2025111413-A1 | TREATMENT FOR SKIN DISORDERS | Mycotechnology, Inc. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-118750451-A | Oxacillin sodium for injection and preparation method thereof | 杭州沐源生物医药科技有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-118716338-A | Application of temperature-sensitive composite gel in bacterial biofilm dissipation | 北京化工大学 | 2024-10-01 | — | — | CN | claimed |
| CN-118667228-A | Antibacterial gelatin sponge and preparation method thereof | 苏州大学附属第一医院 | 2024-09-20 | — | — | CN | claimed |
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| CN-117982740-B | Absorbable biomedical polymer material, ligature clip and preparation method | 四川国纳科技有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-117982740-A | Absorbable biomedical polymer material, ligature clip and preparation method | 四川国纳科技有限公司 | 2024-05-07 | — | — | CN | claimed |
| WO-2004004658-A2 | METHODS AND COMPOSITIONS RELATING TO ISOLEUCINE BOROPROLINE COMPOUNDS | POINT THERAPEUTICS, INC. (US) | 2004-01-15 | — | — | WO | claimed |
| US-20020044968-A1 | High amount of plasticizer to facilitate plasticization of the matrix material at low shear and then reduced prior to adding the encapsulant to reduce post extrusion | GENERAL MILLS, INC. | 2002-04-18 | — | — | US | claimed |
| JP-2002511777-A | — | — | 2002-04-16 | — | — | JP | claimed |
| EP-1119345-A1 | ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES | GENERAL MILLS, INC. (US) | 2001-08-01 | — | — | EP | claimed |
| WO-2000021504-A1 | ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES | GENERAL MILLS, INC. (US) | 2000-04-20 | — | — | WO | claimed |
| EP-0935523-A4 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | GEN MILLS INC (US) | 1999-12-29 | — | — | EP | claimed |
| EP-0935523-A1 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | GENERAL MILLS, INC. (US) | 1999-08-18 | — | — | EP | claimed |
| WO-1998018610-A1 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | LENGERICH BERNHARD H VAN (US) | 1998-05-07 | — | — | WO | claimed |
| US-4024871-A | POLYURETHANE | ETHICON, INC. (US) | 1977-05-24 | — | — | US | claimed |
| US-3987797-A | ANTIMICROBIAL SUTURES | ETHICON, INC. (US) | 1976-10-26 | — | — | US | claimed |